HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.

Abstract
Carbonic anhydrase IX (CA IX) is frequently expressed in human carcinomas and absent from the corresponding normal tissues. Strong induction by tumor hypoxia predisposes CA IX to serve as a target for cancer diagnostics and therapy. Here we evaluated targeting properties and pharmacokinetics of CA IX-specific monoclonal antibody (MAb) M75. Binding parameters of (125)I-labeled M75, including equilibrium dissociation constant, hypoxia-related binding to various cell lines and internalization, were analyzed in vitro. Biodistribution of (125)I-M75 in nude mice bearing HT-29 human colorectal carcinoma xenografts with hypoxic pattern of CA IX expression was studied by measurements of radioactivity in dissected tissues and macroautoradiography of tissue sections. Pharmacokinetics of intravenously administered (125)I-M75 was described using a 2-compartment model. Blood clearance showed a distribution phase t(1/2)(alpha) = 3.4 hr and an elimination phase t(1/2)(beta) = 55.3 hr postinjection. Despite predominant CA IX localization in less accessible perinecrotic regions, (125)I-M75 exhibited specific accumulation in xenograft, with a mean uptake of 15.3 +/- 3.6% of injected dose per gram of tumor tissue at 48 hr postadministration. Specificity of M75 localization was confirmed by low tumor uptake of control antibody. Altogether, our data demonstrate that M75 MAb is a promising tool for selective immunotargeting of hypoxic human tumors that express CA IX.
AuthorsAdrián Chrastina, Jan Závada, Seppo Parkkila, Stefan Kaluz, Milota Kaluzová, Július Rajcáni, Jaromír Pastorek, Silvia Pastoreková
JournalInternational journal of cancer. Journal international du cancer (Int J Cancer) Vol. 105 Issue 6 Pg. 873-81 (Jul 20 2003) ISSN: 0020-7136 [Print] United States
PMID12767076 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2003 Wiley-Liss, Inc.
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Iodine Radioisotopes
  • M75 monoclonal antibody
  • Neoplasm Proteins
  • CA9 protein, human
  • Carbonic Anhydrases
Topics
  • Animals
  • Antibodies, Monoclonal (metabolism, pharmacokinetics)
  • Antibody Specificity
  • Antigens, Neoplasm (immunology, metabolism)
  • Autoradiography
  • Biomarkers, Tumor (immunology, metabolism)
  • Carbonic Anhydrases (immunology, metabolism)
  • Carcinoma (enzymology, metabolism, pathology)
  • Cell Hypoxia
  • Colorectal Neoplasms (enzymology, metabolism, pathology)
  • HT29 Cells
  • Humans
  • Immunohistochemistry
  • Iodine Radioisotopes
  • Kinetics
  • Mice
  • Mice, Nude
  • Neoplasm Proteins (immunology, metabolism)
  • Tissue Distribution
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: